Your webinar registration includes access to the recording in AMWA Online Learning.
Humans have been communicating about disease outbreaks since early recorded human history. You would think it would be easier by now, but it remains a challenge for even the best communicators among us. Learn the latest about the rapidly evolving coronavirus situation so that you can arm yourself with facts to communicate clearly and accurately to help your communities and clients navigate the situation. You can apply the tips and recommendations you learn here to help you communicate effectively when the next unexpected and escalating public crisis erupts.
The webinar is presented by Larry Lynam, DSc, MA, RM, SM, who has 30 years of experience in the biopharmaceutical industry involved in infectious diseases programs developing viral and bacterial vaccines. Larry is prolific on social media and has posted more than 5,000 messages on social media about the coronavirus outbreak. He will provide a resource list he uses to help him prepare and manage his communications.
After participating in this webinar, participants should be able to
· Define terms related to communicating information about viral outbreaks
· Discuss reliable sources for information on the coronavirus and other viral outbreaks
Target Audience: Medical communicators of all levels
About the Presenter: Larry Lynam, DSc, MA, RM, SM
A microbiologist by education and training; in 2009, Larry formed The Lynam Group, LLC., a scientific and medical communications organization specializing in the development of training materials on a wide range of clinical topics and disease states for a variety of professional and lay audiences. After obtaining degrees from Auburn University, Larry began his career as a hospital clinical microbiologist and moved into the evolving biotech industry developing diagnostic tests for detecting viral diseases in both human and animal medicine. He then spent a 30-year career in the biopharmaceutical industry involved in infectious diseases programs developing viral and bacterial vaccines as well as biologic treatments for a range of diseases and conditions.